The effect of the intracerebroventricular injection of Ghrelin agonist on diabetes type 2 disease in male wistar rats
Tóm tắt
Ghrelin, a peptide hormone, synthesized in the stomach, has an effect on glucose metabolism and on blood pressure. The aim of this study is to investigate the effect of an exogenous ghrelin agonist in patients with type 2 diabetes. Three groups of rats were studied: control, sham and experimental (N = 6). After ascertaining that there were diabetic rats in both the control and experimental groups, a dose of 3nM of ghrelin agonist and normal saline was injected through a cannula into the right ventricle in the rats in the experimental and control groups. The results showed a decrease in serum glucose in the experimental group compared to the first day. This difference is comparable between the experimental (*P ≤ 0.05) and the sham group. It is concluded that the injection of a ghrelin agonist (3nM) probably reduces glucose-induced secretion by the pancreatic islets. Under physiological conditions, therefore, ghrelin agonist may modulate the secretion of insulin.
Tài liệu tham khảo
Maassen JA, ‘T Hart LM, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, et al. Mitochondrial Diabetes, Molecular Mechanisms and Clinical Presentation. Diabetes. 2004;53:103–9.
Ceriello A. Perspectives in Diabetes; Postprandial Hyperglycemia and Diabetes Complications; Is It Time to Treat? Diabetes. 2005;54:1–7.
Nogueira AI, Souza Santos RA, Simões E, Silva AC, Cabral AC, Vieira RL, et al. The Pregnancy-induced increase of Plasma angiotensin (1–7) is blunted in gestational diabetes. Regulatory Peptides. 2007;141:55–60.
Schwar Peter EH, Bornstein Stefan R, Markolf H. Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects. Diabetes research and Clinical Practice. 2006;77:148–50.
Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes. 2002;51:124–29.
Rindi G, Necchi V, Savio A, Torsello A, Zoli M, Locatelli V, et al. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochem Cell Biol. 2002;117:511–19.
Salehi A, Dornonville de la Cour C, Håkanson R, Lundquist I. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regul Pept. 2004;118:143–50.
Prodam F, Me E, Riganti F, Gramaglia E, Bellone S, Baldelli R, et al. The nutritional control of ghrelin secretion in humans: the effects of enteral vs. parenteral nutrition. Eur J Nutr. 2006;45:399–405.
Sharma M, Siddique MW, Shamim Akhter M, Gyanesh S, Pillai KK. Evaluation of Antidiabetic and Antioxidant Effects of Seabuckthorn (Hippophaerhamnoides L.) in Streptozotocin-Nicotinamide Induced Diabetic Rats. The Open Conference Proceedings Journal. 2011;2:53–8.
Wang B, Li Y, Liu X, Liu S, Sun C. Effect of the duration of high-fat diet and the dosage of streptozotocin on establishing experimental animal model of type 2 diabetes mellitus. Wei Sheng Yan Jiu. 2011;40:99–102.
Murdolo G, Lucidi P, Di Loreto C, Parlanti N, De Cicco A, Fatone C, et al. Insulin is required for prandial ghrelin suppression in humans. Diabetes. 2003;52:2923–27.
Spranger J, Ristow M, Otto B, Heldwein W, Tschöp M, Pfeiffer AFH, et al. Post-prandial decrease of human plasma ghrelin in the absence of insulin. J Endocrinol Invest. 2003;26:19–22.
Caixás A, Bashore C, Nash W, Pi-Sunyer F, Laferrère B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab. 2002;87:1902.
Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002;87:240–44.
Briatore L, Andraghetti G, Cordera R. Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. Eur J Endocrinol. 2003;149:403–6.
Monteleone P, Bencivenga R, Longobardi N, Serritella C, Maj M. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J Clin Endocrinol Metab. 2003;88:5510–14.